UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 195

Sortiert nach

Probiotics as Adjuvant Treatment for Psychiatric Disorders: A Systematic Review

European psychiatry, 2023-03, Vol.66 (S1), p.S242-S243

2023

Volltextzugriff (PDF)

Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report

European psychiatry, 2023-03, Vol.66 (S1), p.S295-S295

2023

Volltextzugriff (PDF)

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial

Molecular psychiatry, 2016-08, Vol.21 (8), p.1050-1056

2016

Volltextzugriff (PDF)

What do doctors really want and need from their patients?

Journal of affective disorders, 2008, Vol.107, p.S42-S43

Milev, R

2008

Volltextzugriff (PDF)

Anticipated discrimination among people with schizophrenia

Acta psychiatrica Scandinavica, 2012-01, Vol.125 (1), p.77-83

2012

Volltextzugriff (PDF)

Maintenance Repetitive Transcranial Magnetic Stimulation (RTMS) in Relapse Prevention of Depression

European psychiatry, 2015-03, Vol.30, p.836-836

2015

Volltextzugriff (PDF)

EPA-0784 – Overcoming stigma in mood disorders: a new psychoeducational and behviour modification course

European psychiatry, 2014, Vol.29, p.1-1

2014

Volltextzugriff (PDF)

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study

Schizophrenia research, 2009-08, Vol.113 (1), p.41-48

2009

Volltextzugriff (PDF)

Synthesis and characterization of TiOx nanoparticles prepared by pulsed-laser ablation of Ti target in water

Applied surface science, 2009-03, Vol.255 (10), p.5351-5354

2009

Volltextzugriff (PDF)

Stigma and Discrimination in People Suffering with a Mood Disorder: A Cross-Sectional Study

Depression Research and Treatment, 2012, Vol.2012, p.724848-9

2012

Volltextzugriff (PDF)

MEDS

Journal of affective disorders, 2008, Vol.107, p.S27-S27

2008

Volltextzugriff (PDF)

Transcranial magnetic stimulation of the supplementary motor area in the treatment of obsessive-compulsive disorder: A multi-site study

European neuropsychopharmacology, 2019, Vol.29, p.S497-S498

2019

Volltextzugriff (PDF)

Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial

Pain (Amsterdam), 2016-07, Vol.157 (7), p.1532-1540

2016

Volltextzugriff (PDF)

Corrigendum to “A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study” Schizophr. Res. 113 (2009) 41-48

Schizophrenia research, 2011-12, Vol.133 (1), p.266-266

2011

Volltextzugriff (PDF)

Panic disorder

Journal of affective disorders, 2008, Vol.107, p.S27-S27

2008

Volltextzugriff (PDF)

P.2.c.023 Sleep architecture in olanzapine treated patients with depression: a double blind randomized placebo controlled trial

European neuropsychopharmacology, 2010, Vol.20, p.S380-S381

2010

Volltextzugriff (PDF)

Structural and optical properties of YVO4 thin films

Applied surface science, 2007-07, Vol.253 (19), p.8250-8253

2007

Volltextzugriff (PDF)

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study

International journal of clinical practice (Esher), 2010-10, Vol.64 (11), p.1520-1529

2010

Volltextzugriff (PDF)

Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey

The Lancet (British edition), 2009-01, Vol.373 (9661), p.408-415

2009

Volltextzugriff (PDF)

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder

Canadian journal of psychiatry, 2021-12, Vol.66 (12), p.1102-1102

2021

Volltextzugriff (PDF)

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

Bipolar disorders, 2005-06, Vol.7 (s3), p.5-69

2005

Volltextzugriff (PDF)

Relationships Among Neurocognition, Symptoms, and Functioning in Treatment-Resistant Depression

Archives of clinical neuropsychology, 2013-05, Vol.28 (3), p.272-281

2013

Volltextzugriff (PDF)

Different Neural Responses to a Moral Valence Decision Task in Unipolar and Bipolar Depression

ISRN psychiatry, 2013-12, Vol.2013, p.568617-10

2013

Volltextzugriff (PDF)

Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study

CNS spectrums, 2021-06, Vol.26 (3), p.290-298

2021

Volltextzugriff (PDF)

Strong evidence for association between the dystrobrevin binding protein 1 gene ( DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria

Biological psychiatry (1969), 2004-05, Vol.55 (10), p.971-975

2004

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(177)
Mit Volltextzugriff
(175)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Probiotics as Adjuvant Treatment for Psychiatric Disorders: A Systematic Review

Pro-inflammatory markers predict response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 report

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial

What do doctors really want and need from their patients?

Anticipated discrimination among people with schizophrenia

Maintenance Repetitive Transcranial Magnetic Stimulation (RTMS) in Relapse Prevention of Depression

EPA-0784 – Overcoming stigma in mood disorders: a new psychoeducational and behviour modification course

A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study

Synthesis and characterization of TiOx nanoparticles prepared by pulsed-laser ablation of Ti target in water

Stigma and Discrimination in People Suffering with a Mood Disorder: A Cross-Sectional Study

MEDS

Transcranial magnetic stimulation of the supplementary motor area in the treatment of obsessive-compulsive disorder: A multi-site study

Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial

Corrigendum to “A randomized controlled trial of the effect of sublingual orally disintegrating olanzapine versus oral olanzapine on body mass index: The PLATYPUS Study” Schizophr. Res. 113 (2009) 41-48

Panic disorder

P.2.c.023 Sleep architecture in olanzapine treated patients with depression: a double blind randomized placebo controlled trial

Structural and optical properties of YVO4 thin films

An exploratory analysis of factors associated with weight change in a 16-week trial of oral vs. orally disintegrating olanzapine: the PLATYPUS study

Global pattern of experienced and anticipated discrimination against people with schizophrenia: a cross-sectional survey

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder

Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies

Relationships Among Neurocognition, Symptoms, and Functioning in Treatment-Resistant Depression

Different Neural Responses to a Moral Valence Decision Task in Unipolar and Bipolar Depression

Modeling psychological function in patients with schizophrenia with the PANSS: an international multi-center study

Strong evidence for association between the dystrobrevin binding protein 1 gene ( DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria

Suchergebnisse filtern